Carnitines and Its Congeners: A Metabolic Pathway to the Regulation of Immune Response and Inflammation
- 1 November 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1033 (1), 132-138
- https://doi.org/10.1196/annals.1320.012
Abstract
Carnitine and its congeners may regulate the immune networks, and their influence on functions of immune cells predominantly or exclusively relies on carnitine-dependent energy production from fatty acids. A reduced pool of carnitines has been demonstrated in either serum or tissues, or both, from patients with a wide spectrum of disorders characterized by unregulated or impaired immune responses ranging from sepsis syndrome to systemic sclerosis, infection with human immunodeficiency virus, and chronic fatigue syndrome. Furthermore, experimental studies have consistently reported that the deranged immune responses and the less efficient inflammation towards infectious organisms associated with aging may be enhanced or modulated by treatment with carnitines. There is also evidence that carnitine deprivation could adversely affect the course of the sepsis syndrome, at least in experimental models, and preliminary studies suggest that carnitine deficiency is ultimately implicated in the pathophysiology of endotoxin-mediated multiple organ failure. Several data indicate that carnitine deficiency is a contributing factor to the progression of infection with human immunodeficiency virus, and carnitine therapy in those patients could counteract the unregulated process of lymphocyte apoptosis and improve CD4 counts. Some case reports have suggested the use of carnitine for the treatment of the severe lactic acidosis that complicates in some patients the use of reverse transcriptase inhibitorKeywords
This publication has 32 references indexed in Scilit:
- Severe Lactic Acidosis in Association with Reverse Transcriptase Inhibitors with Potential Response to L-Carnitine in a Pediatric HIV-Positive PatientAIDS Patient Care and STDs, 2004
- Effect of L-Carnitine on Carrageenan-Induced Inflammation in Aged RatsGerontology, 2003
- Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with l-carnitineCritical Care Medicine, 2003
- Effects of ?-carnitine on neutrophil functions in aged ratsMechanisms of Ageing and Development, 2003
- L-Carnitine Reduces Lymphocyte Apoptosis and Oxidant Stress in HIV-1-Infected Subjects Treated with Zidovudine and DidanosineAntioxidants and Redox Signaling, 2002
- L-Carnitine Changes the Levels of Insulin-like Growth Factors (IGFs) and IGF Binding Proteins in Streptozotocin-induced Diabetic Rat.Journal of Nutritional Science and Vitaminology, 2001
- Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trialAmerican Journal of Kidney Diseases, 1999
- Cell-associated ceramide in HIV-1 -infected subjectsAIDS, 1996
- Ceramide, AIDS and long-term survivorsImmunology Today, 1996
- Myopathy and HIV infectionCurrent Opinion in Rheumatology, 1995